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Impact of the isolation medium for detection of carbapenemase-producing Enterobacteriaceae using an updated version of the Carba NP test
Carbapenem resistance in
Enterobacteriaceae is now emerging worldwide at an alarming rate, causing both nosocomial and now communityacquired infections (Nordmann et al., 2012a) . A variety of carbapenemases have been reported in Enterobacteriaceae such as KPC (Ambler class A), metallo-blactamases of VIM-, IMP-and NDM-type (Ambler class B), and OXA-48-types (Ambler class D). Thus, an efficient strategy for detection of carbapenemase producers is becoming critical for the determination of appropriate therapeutic schemes and the implementation of infection control measures (Nordmann & Poirel, 2013) . Recently, the Carba NP test has been developed for rapid identification of carbapenemase production in Enterobacteriaceae (Nordmann et al., 2012b) . Here, we further improve and evaluate the ability of the Carba NP test to detect carbapenemase producers among Enterobacteriaceae recovered from various commercial media (selective, non-selective and screening media) used in clinical situations.
Fifty carbapenemase-producers (10 OXA-48, 10 KPC, 10 VIM, 10 NDM and 10 IMP) were included in the study (Table 1) . Twelve non-carbapenemase-producing enterobacterial strains non-susceptible to carbapenems were also included. All strains had previously been characterized for their b-lactamase content at the molecular level (Nordmann et al., 2012b) . Susceptibilities to carbapenems were determined by Etest (bioMérieux) and interpreted according to EUCAST breakpoints (www.eucast.org/clinical_ breakpoints/), as updated in 2013.
Prior to performing the Carba NP test, all strains were grown at 37 u C for 24 h on the following media.
(i) Non-selective media were Columbia agar + 5 % sheep blood (bioMérieux), Tryticase soy agar (bioMérieux) and the non-selective chromogenic medium UriSelect 4 (Bio-Rad).
(ii) Gram-negative bacilli (GNB) selective media were Drigalski agar (Bio-Rad) and MacConkey agar (Becton Dickinson).
(iii) Screening media for screening extended-spectrum b lactamase (ESBL) or carbapenemase producers were ChromID ESBL (bioMérieux), Brilliance CRE Agar (Oxoid) and CHROMagar KPC (CHROMagar). The Carba NP test is based on the colorimetric detection of hydrolysis of the b-lactam ring of a carbapenem molecule, imipenem (Nordmann et al., 2012b) . We have further improved the Carba NP test by using 1.5 ml Eppendorf tubes instead of 96-well microplates and by using a reduced amount of bacteria (1/4 to 1/3 of a calibrated 10 ml loop resuspended in 100 ml of lysis buffer). These modifications simplify the lysis step for obtaining the bacterial extracts, eliminating the need for a centrifugation step (see methods available in the online Supplementary Material).
Our results confirmed the excellent sensitivity (100 %) and specificity (100 %) of the Carba NP test when bacterial isolates were recovered on non-selective rich media (i.e. Columbia blood agar and trypticase soy agar) ( Since the prevention of carbapenemaseproducing Enterobacteriaceae dissemination relies on accurate detection of colonized patients, three screening media were evaluated (CHROMagar KPC, Brilliance CRE and ChromID ESBL).
As soon as the bacterial isolates were able to grow on those selective media, the Carba NP test differentiated perfectly between carbapenemase and non-carbapenemase producers ( Table 1) .
The Carba NP test was recently demonstrated to be of great value for excellent and rapid identification of carbapenemase producers (of any type) (Milillo et al., 2013; Nordmann et al., 2012b; Tijet et al., 2013; Vasoo et al., 2013) . However, these data were obtained with bacterial isolates grown on only one type of MH agar (Becton Dickinson). In this study, we demonstrated that the Carba NP test might be performed on rich media in current use to isolate clinical samples, such as blood agar and trypticase soy agar. Moreover, when considering urine specimens, chromogenic non-selective media, such as UriSelect 4 medium, are often used in clinical microbiology to provide presumptive identification of the bacterial species responsible for urinary tract infections (UTIs). In the case of UTIs caused by a carbapenemase-producing isolate, our results showed that the Carba NP test might be performed directly on the chromogenic medium with 100 % sensitivity and specificity. These results are of utmost importance, especially in endemic situations of carbapenemase producers (Nordmann et al., 2012a) .
Our results indicate that the zinc concentration in MH agar of the medium is crucial for efficient detection of VIM and NDM-type carbapenemases. These results are similar to those obtained with the modified Hodge test, for which higher sensitivity can be obtained using zinc-supplemented plates. However, with the Carba NP test, the IMP enzymes were always detected regardless of the zinc content of the MH agar used. The higher catalytic activity of IMP-1 compared with NDM-1 and VIM-2 (Yong et al., 2009) , coupled with its active site plasticity, might explain these results (Horton et al., 2012) .
Finally, 30 % of the strains gave noninterpretable results when bacterial colonies were recovered from Drigalski or MacConkey agar, regardless of carbapenemase production. Such results might be a consequence of the accumulation of lactic acid in the bacterial isolates that were able to ferment lactose. Therefore, the Carba NP test is not suitable to identify carbapenemase producers grown on Drigalski agar and MacConkey agar plates.
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